Overview

Cost Comparison Study of Darbepoetin Versus Epoetin Therapy to Treat Anemia in Hemodialysis Patients

Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if there is a cost difference between darbepoetin alfa and epoetin alfa when used intravenously to treat anemia in hemodialysis patients.
Phase:
Phase 4
Details
Lead Sponsor:
Andrea L Woodland
Treatments:
Darbepoetin alfa
Epoetin Alfa
Ferric gluconate